Clinical Trial

Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated April 29, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
A multicenter, randomized, double-Blind, crossover, placebo-controlled Phase II clinical Study to evaluate the efficacy and safety of BRIMOCHOL PF and CARBACHOL PF in the treatment of Chinese patients with presbyopia.
Trial Details
NCT Number NCT06948357
Lead Sponsor Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Conditions Presbyopia
Enrollment 119 participants
Start Date 2025-03-24
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-29